Skip to content

CIK 0001844280

THRN Thorne Healthtech, Inc.

Insider trading from SEC Form 4. Last filing Oct 18, 2023.

In brief

Thorne Healthtech, Inc. (THRN) has 24 SEC Form 4 filings on file from 9 insiders, the latest filed on Oct 18, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Signals

Open-market buys and sells at Thorne Healthtech, Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The newest 50 of 51 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 16, 2023Sarah M Kauss
director
DDisposition to issuer
Common Stock
-105,874--0Oct 18, 2023
Apr 4, 2023William C. McCamy
President
FTax withholding
Common Stock
-7,571$4.72$36k389,804Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Common Stock
-589,804--0Oct 18, 2023
Oct 16, 2023Riccardo Braglia
director
DDisposition to issuer
Common Stockindirect: See Footnote
-5,424,550--0Oct 18, 2023
Mar 24, 2023Thomas P. McKenna
Chief Operating Officer
FTax withholding
Common Stock
-11,257$4.70$53k795,740Oct 18, 2023
Apr 4, 2023Saloni S. Varma
Chief Financial Officer
FTax withholding
Common Stock
-3,454$4.72$16k81,643Oct 18, 2023
Apr 4, 2023Paul F Jacobson
Chief Executive Officer
FTax withholding
Common Stock
-45,338$4.72$214k1,825,966Oct 18, 2023
Mar 24, 2023Paul F Jacobson
Chief Executive Officer
FTax withholding
Common Stock
-59,907$4.70$282k1,871,304Oct 18, 2023
Oct 16, 2023Thomas P. McKenna
Chief Operating Officer
DDisposition to issuer
Common Stock
-1,172,227--0Oct 18, 2023
Oct 16, 2023Saloni S. Varma
Chief Financial Officer
DDisposition to issuer
Common Stock
-581,643--0Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Common Stock
-2,105,589--0Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-156,640$0.00$00Oct 18, 2023
Oct 16, 2023Riccardo Braglia
director
DDisposition to issuer
Warrant (Right to buy)derivativeindirect: See Footnote
-453,455$0.00$00Oct 18, 2023
Oct 16, 2023Thomas P. McKenna
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-89,000$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Common Stockindirect: See Footnote
-220,377--0Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-17,355$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Common Stockindirect: See Footnote
-1,602,445--0Oct 18, 2023
Oct 16, 2023Thomas P. McKenna
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-178,000$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-31,150$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-208,100$0.00$00Oct 18, 2023
Oct 16, 2023Thomas P. McKenna
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-186,900$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-39,605$0.00$00Oct 18, 2023
Oct 16, 2023Thomas P. McKenna
Chief Operating Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-639,910$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-244,750$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-244,750$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-89,000$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-1,279,375$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-178,000$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-36,045$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-186,900$0.00$00Oct 18, 2023
Oct 16, 2023Paul F Jacobson
Chief Executive Officer
DDisposition to issuer
Warrant (Right to buy)derivativeindirect: See Footnote
-2,532,050$0.00$00Oct 18, 2023
Oct 16, 2023William C. McCamy
President
DDisposition to issuer
Employee Stock Option (Right to buy)derivative
-639,910$0.00$00Oct 18, 2023
Oct 16, 2023Mitsui & Co Ltd
owner
UTender of shares
Common Stock
-15,674,235--0Oct 17, 2023
Oct 12, 2023Kirin Holdings Company, Ltd /FI
owner
UTender of shares
Common Stock
-15,674,235$10.20$160M0Oct 17, 2023
Oct 16, 2023Mitsui & Co Ltd
owner
JOther
Class A Common Stock Warrant (Right to buy)derivative
-56,515--0Oct 17, 2023
Oct 12, 2023Kirin Holdings Company, Ltd /FI
owner
XIn-the-money exercise
Warrants (right to buy)derivative
-56,515--0Oct 17, 2023
Apr 4, 2023Paul F Jacobson
Chief Executive Officer
FTax withholding
Common Stock
-40,556$4.72$191k1,838,036Apr 6, 2023
Apr 4, 2023Sarah M Kauss
director
AGrant or award
Common Stock
+30,000$0.00$0105,874Apr 6, 2023
Apr 4, 2023William C. McCamy
President
FTax withholding
Common Stock
-7,609$4.72$36k389,766Apr 6, 2023
Apr 4, 2023Thomas P. McKenna
Chief Operating Officer
FTax withholding
Common Stock
-23,513$4.72$111k772,044Apr 6, 2023
Apr 4, 2023Saloni S. Varma
Chief Financial Officer
FTax withholding
Common Stock
-6,430$4.72$30k78,667Apr 6, 2023
Apr 4, 2023Paul F Jacobson
Chief Executive Officer
AGrant or award
Common Stock
+500,000$0.00$02,338,036Apr 6, 2023
Apr 4, 2023William C. McCamy
President
AGrant or award
Common Stock
+200,000$0.00$0589,766Apr 6, 2023
Apr 4, 2023Thomas P. McKenna
Chief Operating Officer
AGrant or award
Common Stock
+400,000$0.00$01,172,044Apr 6, 2023
Apr 4, 2023Saloni S. Varma
Chief Financial Officer
AGrant or award
Common Stock
+500,000$0.00$0578,667Apr 6, 2023
Mar 24, 2023Paul F Jacobson
Chief Executive Officer
FTax withholding
Common Stock
-52,619$4.70$247k1,878,592Mar 28, 2023
Mar 24, 2023Thomas P. McKenna
Chief Operating Officer
FTax withholding
Common Stock
-11,440$4.70$54k795,557Mar 28, 2023
Dec 1, 2022Bryan K. Conley
Chief Financial Officer
FTax withholding
Common Stock
-7,838$4.89$38k222,162Dec 5, 2022
Dec 1, 2022Paul F Jacobson
Chief Executive Officer
FTax withholding
Common Stock
-45,338$4.89$222k1,931,211Dec 5, 2022
Dec 1, 2022William C. McCamy
President
FTax withholding
Common Stock
-12,175$4.89$60k397,375Dec 5, 2022
50 of 51 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about THRN

Answered from the filings on this page, as of the latest one.

Are insiders buying THRN?

No. In the last 90 days no insider at Thorne Healthtech, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade THRN on the open market?

No open-market trade has been scored at Thorne Healthtech, Inc.. The latest Form 4 on file was filed on Oct 18, 2023 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Thorne Healthtech, Inc.?

9 people have filed a Form 4 at Thorne Healthtech, Inc., among them Riccardo Braglia (director), Bryan K. Conley (Chief Financial Officer), Paul F Jacobson (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

THRN insider trading: Thorne Healthtech, Inc. | InsiderTell